Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADALIMUMAB-ATTO for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 43 adverse event reports in the FDA FAERS database where ADALIMUMAB-ATTO was used for Psoriasis.

Most Reported Side Effects for ADALIMUMAB-ATTO

Side Effect Reports % Deaths Hosp.
Device difficult to use 328 28.6% 0 4
Product storage error 279 24.4% 0 0
Drug dose omission by device 219 19.1% 0 4
Circumstance or information capable of leading to medication error 194 16.9% 0 0
Accidental exposure to product 123 10.7% 0 0
Injection site pain 100 8.7% 0 0
Intercepted product administration error 75 6.5% 0 0
Wrong technique in product usage process 69 6.0% 0 0
Drug ineffective 48 4.2% 2 13
Off label use 47 4.1% 2 13
Product communication issue 46 4.0% 0 1
Pain 33 2.9% 2 15
Rheumatoid arthritis 33 2.9% 2 15
Device use error 29 2.5% 0 0
Arthralgia 25 2.2% 2 12

Other Indications for ADALIMUMAB-ATTO

Product used for unknown indication (660) Rheumatoid arthritis (138) Inflammatory bowel disease (69) Crohn's disease (58) Psoriatic arthropathy (56) Colitis ulcerative (26) Ankylosing spondylitis (19) Arthritis (16) Hidradenitis (14) Uveitis (9)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

ADALIMUMAB-ATTO Full Profile All Psoriasis Drugs ADALIMUMAB-ATTO Demographics ADALIMUMAB-ATTO Timeline